Organon executive exercises 7,979 RSUs

Organon & Co.'s Interim Head of Manufacturing & Supply, Juliana Papa Drinane, exercised 7,979 Restricted Stock Units into common stock on March 29, 2026.

Rhea-AI Filing Summary

Organon & Co.'s Interim Head of Manufacturing & Supply, Juliana Papa Drinane, exercised 7,979 Restricted Stock Units into common stock on March 29, 2026. To cover taxes, 2,733 shares were withheld at $5.84 per share. She now directly holds 22,420.703 Organon common shares, reflecting a routine compensation-related equity increase.

Insider Trade Summary

7,979 shares exercised/converted

Exercise 3 txns

Insider Drinane Juliana Papa

Role Interim Head of Mfg & Supply

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	7,979	$0.00	$0.00
Exercise	Common Stock	7,979	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,733	$5.84	$16K

Holdings After Transaction: Restricted Stock Units — 7,979 contracts (Direct); Common Stock — 22,420.703 shares (Direct)

Footnotes (3)

1. F1. This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
2. F2. Each RSU represents a contingent right to receive one share of Organon common stock.
3. F3. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.

Key Figures

RSUs exercised: 7,979 units Tax withholding shares: 2,733 shares Withholding price: $5.84/share +3 more

6 metrics

RSUs exercised 7,979 units Restricted Stock Units converted to common stock on March 29, 2026

Tax withholding shares 2,733 shares Common stock withheld to satisfy tax obligations at $5.84 per share

Withholding price $5.84/share Closing market price on March 27, 2026 used for tax withholding

Post-transaction holdings 22,420.703 shares Direct Organon common stock owned after the reported transactions

Net shares retained 5,246 shares RSU shares acquired minus 2,733 shares withheld for taxes

RSU vesting schedule 3 equal installments Vesting on March 29, 2025, 2026, and 2027

Key Terms

Restricted Stock Units, tax-withholding disposition, Exercise or conversion of derivative security, contingent right, +1 more

5 terms

Restricted Stock Units financial

"This price is the closing market price of Organon & Co. common stock ... under which the Restricted Stock Units ("RSU") were awarded."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

contingent right financial

"Each RSU represents a contingent right to receive one share of Organon common stock."

vesting financial

"These RSUs vest and are distributed as shares of Organon common stock in three equal installments..."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Organon (OGN) report for Juliana Papa Drinane?

Organon reported that Interim Head of Manufacturing & Supply Juliana Papa Drinane exercised 7,979 Restricted Stock Units into common stock. This compensation-related event increased her direct equity stake in Organon and was paired with share withholding to satisfy tax obligations.

How many Organon (OGN) shares did the insider receive and retain from the RSU exercise?

She acquired 7,979 shares of Organon common stock through RSU vesting and exercise. After 2,733 shares were withheld to cover taxes, she retained a net 5,246 shares, bringing her direct ownership to 22,420.703 shares following the reported transactions.

Was there any open-market buying or selling in this Organon (OGN) Form 4?

No open-market buying or selling occurred. The Form 4 shows RSU vesting with an option exercise coded “M” and a tax-withholding disposition coded “F.” These are compensation and tax events, not discretionary market trades in Organon stock.

What was the tax withholding price used for the Organon (OGN) shares?

The tax withholding transaction used a share price of $5.84. According to the footnote, this reflects the closing market price of Organon common stock on March 27, 2026, as required by the company’s plan governing the Restricted Stock Units.

How do Organon (OGN) Restricted Stock Units work in this insider filing?

Each Restricted Stock Unit in this filing represents a contingent right to receive one share of Organon common stock. The RSUs vest and are distributed in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027, according to the disclosed vesting schedule.

What is Juliana Papa Drinane’s Organon (OGN) shareholding after this Form 4?

After the RSU exercise and tax withholding, Juliana Papa Drinane directly holds 22,420.703 shares of Organon common stock. This total reflects her updated position following the compensation-related equity transaction reported on March 29, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/31/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Drinane Juliana Papa

(Last) (First) (Middle)

C/O ORGANON &CO.

30 HUDSON STREET, FLOOR 33

(Street)

JERSEY CITY NEW JERSEY 07302

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Organon & Co. [ OGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim Head of Mfg & Supply

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/29/2026		M		7,979	A	$0	25,153.703	D
Common Stock	03/29/2026		F		2,733	D	$5.84(1)	22,420.703	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	03/29/2026		M			7,979	03/29/2026(3)	03/29/2027(3)	Common Stock	7,979	$0	7,979	D

Explanation of Responses:

1. This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.

2. Each RSU represents a contingent right to receive one share of Organon common stock.

3. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.

Remarks:

	/s/ Tarnetta V. Jones, as Attorney-in-Fact for Juliana Drinane	03/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)